Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered ...

At the Liver Meeting sponsored by the American Association for the Study of Liver Diseases, investigators presented new insights into how the immune makeup of fibrotic tissue may influence ...

Dr. Anjana Pillai says treatment depends on stage and health, with surgery, transplant, local therapy or systemic drugs to help people live longer. Dr. Anjana Pillai explains, in an interview with ...

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...

A new Cedars-Sinai Cancer study shows that patients with advanced liver cancer who receive immunotherapy to shrink their tumors have improved outcomes after liver transplant or tumor removal.

AMSTERDAM, the Netherlands — For patients with unresectable intermediate-stage hepatocellular carcinoma, selective internal radioembolization and standard transarterial chemoembolization provide ...

The industry currently witnesses a paradigm shift toward combination regimens, where oral kinase inhibitors and ...

Unexplained weight loss can signal liver cancer, especially when accompanied by abdominal discomfort and persistent fullness.